ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 623081 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 623081; 2) Community: the network communities that were significantly associated with the response to NSC 623081; 3) Molecule: the relationships between components within communities and NSC 623081; 4) MDR: the compounds that were significantly associated with the NSC 623081.

NSC Compound Enrichment Correlation
NSC 610457 Camptothecin Derivative 0.0462077035966088 0.081370383
NSC 618296 Null 0.0462077035966088 0.050249783
NSC 622070 Null 0.0462077035966088 -0.021834339
NSC 11668 N4,N6-bis(3-chlorophenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine 0.0467178916101838 -0.29536943
NSC 146604 FUR 0.0467178916101838 -0.15993451
NSC 150094 1-Azabicyclo[2.2.2]octan-3-one, 2-(4-morpholinylmethyl)- 0.0467178916101838 -0.17278827
NSC 15628 Cinnasil 0.0467178916101838 -0.060452183
NSC 166641 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 7-fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride 0.0467178916101838 -0.17315765
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0467178916101838 -0.1639614
NSC 237677 Null 0.0467178916101838 0.11279025
Total:119  Current:112    [First] [Prev] [Next] [Last]